Compass Pathways
Magic mushroom compound matches antidepressant in clinical trial
Phil Taylor
Compass Pathways, depression, Imperial College, mental health, psychedelics
0 Comment
X
Magic mushroom compound matches antidepressant in clinical trial
https://pharmaphorum.com/news/magic-mushroom-compound-matches-antidepressant-in-clinical-trial/
MindMed aims for Nasdaq listing after Compass’ magic mushroom-fuelled IPO
Richard Staines
Compass Pathways, depression, IPO, mental health
0 Comment
X
MindMed aims for Nasdaq listing after Compass’ magic mushroom-fuelled IPO
https://pharmaphorum.com/news/mindmed-aims-for-nasdaq-listing-after-compass-magic-mushroom-fuelled-ipo/
News/ News/ R&D/ Top stories
Compass plans $100m IPO to fund magic mushroom depression drug
Richard Staines
Compass Pathways, depression, IPO, mental health
0 Comment
X
Compass plans $100m IPO to fund magic mushroom depression drug
https://pharmaphorum.com/news/compass-plans-100m-ipo-to-fund-magic-mushroom-depression-drug/